
GUARDANT HEALTH INC
GHNASDAQ๐ #462 by market capEarnings Oct 27 ยท PostUS Equity
$165.09โผ $2.10 (โ1.27%)
Market closed ยท at close1hโ
24hโผ 1.3%
7dโฒ 1.2%
14dโฒ 14.5%
30dโฒ 4.1%
1yโฒ 199.7%
๐ฆMarket Cap
$21.89B
Mid Cap
๐Revenue Growth (YoY)
+42.7%
High Growth
๐Gross Margin
65.0%
High
๐ตFCF Margin
โ
โ๏ธP/S Ratio
19.2x
Expensive
Otter Score
51
Weak
๐
Analyst Ratings
Price
$165.09
Total
31
Raised
2
Lowered
1
Avg PT
$184.50
H / L
$210 / $120
| Institution | Action | Rating | Date |
|---|---|---|---|
JP Morgan | Reiterated | Overweight | 2026-07-31 |
BTIG | Reiterated | Buy | 2026-07-31 |
Barclays | Reiterated | Overweight | 2026-07-31 |
TD Cowen | Reiterated | Buy | 2026-07-31 |
RBC Capital | Reiterated | Outperform | 2026-07-31 |
Mizuho | Reiterated | Outperform | 2026-07-31 |
Guggenheim | Reiterated | Buy | 2026-07-16 |
Canaccord Genuity | Reiterated | Buy | 2026-07-14 |
Morgan Stanley | Reiterated | Overweight | 2026-07-09 |
Citigroup | Reiterated | Buy | 2026-07-08 |
B of A Securities | Reiterated | Buy | 2026-07-06 |
Evercore ISI Group | Reiterated | Outperform | 2026-07-06 |
Bernstein | Reiterated | Outperform | 2026-07-02 |
Goldman Sachs | Reiterated | Buy | 2026-06-05 |
Piper Sandler | Reiterated | Overweight | 2026-02-24 |
Stifel | Reiterated | Buy | 2026-02-20 |
Wells Fargo | Reiterated | Overweight | 2026-02-20 |
Leerink Partners | Reiterated | Outperform | 2026-02-20 |
UBS | Reiterated | Buy | 2025-10-30 |
Wolfe Research | Upgraded | Peer Perform โ Outperform | 2025-09-25 |
Scotiabank | Reiterated | Sector Outperform | 2025-07-31 |
Raymond James | Reiterated | Outperform | 2025-07-31 |
TD Securities | Reiterated | Buy | 2025-05-01 |
Stephens & Co. | Reiterated | Overweight | 2025-03-26 |
Craig-Hallum | Reiterated | Buy | 2024-08-08 |
Credit Suisse | Reiterated | Outperform | 2023-05-10 |
OTR Global | Downgraded | Mixed โ Negative | 2023-05-01 |
Cowen & Co. | Reiterated | Outperform | 2023-02-24 |
SVB Leerink | Reiterated | Outperform | 2022-02-24 |
Bank of America | Upgraded | Neutral โ Buy | 2019-04-10 |
William Blair | Reiterated | Outperform | 2018-10-29 |
One row per institution, most recent rating